로딩 중…
지수 로딩 중…
Capricor Therapeutics, Inc.
CAPR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$28.38+1.54%
2026-06-18
Price Chart
Capricor Therapeutics, Inc.+137.69%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.64B |
| Revenue | $0.00 |
| Net Income | $-115M |
| Total Assets | $326M |
| Net Assets | $279M |
| Value | |
| P/B | 5.90x |
| FCF Yield | -6.93% |
| Profitability | |
| ROE | -41.12% |
| ROA | -35.12% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 17.07% |
| Total Debt | $21M |
| FCF | $-114M |
| Cash | $105M |
| Current Ratio | 8.42x |
| Performance | |
| 1Y Return | 137.69% |
| 1M Return | 5.42% |
| From 52W High | -29.70% |
| 1Y MDD | -67.67% |
| Trading | |
| Volume | 2,081,811 shares |
| Trading Value | $59M |
| Per Share | |
| EPS | $-2.15 |
| BPS | $6.26 |